MRSN Competitors & Alternatives
Compare Mersana Therapeutics Inc with similar stocks in the same industry
Biotechnology
MRSN
Main Stock$29.08
Tradestie Score
56
Market Cap
$39.63M
Revenue Growth
-0.1%
Analyst Upside
+14.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$14.31
|
$211.22M | - | 62 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.96
|
$202.58M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.92
|
$170.45M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.13
|
$158.43M | - | 55 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$27.77
|
$154.27M | - | 54 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$4.40
|
$153.02M | - | 58 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.28
|
$133.50M | - | 56 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.51
|
$114.01M | - | 53 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.29
|
$110.20M | - | 60 | Compare |
|
MGNX
MacroGenics, Inc.
|
$4.82
|
$107.45M | - | 64 | Compare |
More MRSN Analysis
Data updated: Jun 29, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry